Skip to main content
. 2023 Aug 10;21:304. doi: 10.1186/s12916-023-02976-7

Table 3.

Results of the FGR model for 10-year incidence of DR (n = 23,531)

Parameter Crude sHR
(95% CI)
P Adjusted sHR (95% CI) P
Sex (M) 1.07 (1.02, 1.12)  < 0.01** 1.05 (1.01, 1.10)  < 0.05*
DBP (mm Hg) 0.98 (0.95, 1.01) 0.22 - -
HbA1c (%) 1.19 (1.15, 1.24)  < 0.001*** 1.19 (1.15, 1.24)  < 0.001***
HbA1c × NLR# 0.93 (0.90, 0.96)  < 0.001*** 0.94 (0.90, 0.96)  < 0.001***
SBP (mmHg) 1.00 (1.00, 1.01)  < 0.001*** 1.08 (1.06, 1.09)  < 0.001***
Age × NLR# 0.97 (0.94, 1.00) 0.05 0.98 (0.97, 0.98)  < 0.001***
NLR (> 3.04) 2.41 (1.27, 4.57)  < 0.01 2.24 (1.70, 2.94)  < 0.001***
non-HDL-c (mmol/L) 1.04 (0.95, 1.15) 0.35 - -
BMI (kg/m2) 0.99 (0.99, 0.99)  < 0.001*** 0.93 (0.91, 0.94)  < 0.001***
eGFR (ml/min/1.73 m2) 0.96 (0.92, 1.01) 0.16 0.97 (0.95, 0.98)  < 0.001***
Diabetes drug (yes) 1.01 (0.97, 1.07) 0.45 - -
Age (years) 1.01 (0.97, 1.04) 0.60 - -
eGFR × NLR# 1.00 (0.97, 1.04) 0.80 - -

Variables labelled with # represent variable interaction terms with NLR. The effect estimates for eGFR, SBP and DBP are presented for a 10-unit increase whereas age and BMI were shown for a 5-unit increase. The same applies to the interaction terms of these variables with NLR in the multivariate regression models (product term represented by × symbol between variables)

sHR, sub hazard ratio

*p < 0.05; **p < 0.01; ***p < 0.001